BFM
ROIV icon

Boothbay Fund Management’s Roivant Sciences ROIV Stock Holding History

Boothbay Fund Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Buy
77,818
+57,334
+280% +$1.69M 0.04% 577
2026
Q1 		$567K Buy
+20,484
New +$526K 0.01% 1270
2025
Q3 		– Sell
-40,084
Closed -$452K – 2118
2025
Q2 		$452K Sell
40,084
-97,801
-71% -$1.06M 0.01% 938
2025
Q1 		$1.39M Buy
137,885
+110,271
+399% +$1.19M 0.04% 523
2024
Q4 		$327K Sell
27,614
-103
-0.4% -$1.22K 0.01% 1041
2024
Q3 		$320K Hold
27,717
– – 0.01% 1192
2024
Q2 		$293K Hold
27,717
– – 0.01% 1164
2024
Q1 		$292K Sell
27,717
-8,795
-24% -$94.8K 0.01% 1197
2023
Q4 		$410K Buy
+36,512
New +$356K 0.01% 1063
2023
Q3 		– Sell
-45,158
Closed -$455K – 2024
2023
Q2 		$455K Sell
45,158
-97,944
-68% -$876K 0.01% 1146
2023
Q1 		$1.06M Buy
+143,102
New +$1.18M 0.02% 967

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Boothbay Fund Management's ROIV Position: Q2 2026 in Review

Boothbay Fund Management increased its Roivant Sciences (ROIV) stake by 280% in Q2 2026, buying an estimated $1.69M and bringing the position to 77,818 shares worth $2.75M. The position accounts for 0.04% of the portfolio, ranked #577.

Boothbay Fund Management first reported a position in ROIV in Q1 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Boothbay Fund Management held 77,818 shares of Roivant Sciences worth $2.75M as of Q2 2026.
  • Boothbay Fund Management bought 57,334 Roivant Sciences shares in Q2 2026, an estimated $1.69M.
  • Roivant Sciences made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #577 holding.
  • Boothbay Fund Management first reported a position in Roivant Sciences in Q1 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.